Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Registry Study of Treatment With Bulevirtide in Participants With Chronic Hepatitis D Infection

NCT05718700 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT05718700
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05718700 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Registry Study of Treatment With Bulevirtide in Participants With Chronic Hepatitis D Infection
Lead sponsor
Gilead Sciences
Phase
Observational
Overall status
Terminated
Start date
February 7, 2023
Completion date
August 31, 2026
Enrollment
170 (actual)
Sites
53

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis d infection